Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology

被引:20
|
作者
Sibony, Mathilde [1 ]
Vieillefond, Annick [2 ]
机构
[1] Univ Paris 06, Hop Tenon, AP HP, Serv Anat & Cytol Pathol, F-75020 Paris, France
[2] Univ Paris 05, Hop Cochin, AP HP, Serv Anat & Cytol Pathol, F-75014 Paris, France
关键词
Nonclear cell renal cell carcinoma; Papillary renal cell carcinoma; Oncocytoma; Chromophobe renal cell carcinoma; Renal carcinomas associated with Xp11.2 translocations; REST; Miscellaneous tumours; unclassified carcinoma;
D O I
10.1016/j.annpat.2008.07.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Non clear cell renal cell carcinomas represent almost 20% of all renal neoplasms. Their classification is continuously being adjusted according to new cytogenetic and molecular data. Since molecular techniques are expensive, diagnosis still relies on morphological and immuno-histochemical criteria detailed hereby. Papillary renal cell carcinomas are the most important group and its classification is more and more complex. It encompasses low-grade papillary carcinomas (type 1 papillary renal cell carcinoma, oncocytic papillary renal cell carcinoma) and high-grade papillary carcinomas (type 2 papillary renal cell carcinoma, juvenile papillary carcinoma corresponding to renal carcinoma associated with Xp11.2 translocations and unclassified carcinomas). Mucinous tubular and spindle cell carcinoma and tubulocystic carcinoma are new entities, actually considered by some authors as Low-grade papillary carcinomas. The so-called carcinoma of collecting ducts of Bellini and renal medullary carcinoma should be considered as intrarenal urothelial carcinoma or as high-grade papillary or unclassified carcinoma. Sarcomatoid carcinoma derives from morphological progression of any type of renal cell carcinoma. The group of oncocytomas/chromophobe renal cell carcinomas can be considered as a spectrum from benign (oncocytoma) to malignant neoplasm (chromophobe renal cell carcinoma). They are sometimes encountered in oncocytomatosis or familial. Birt-Hogg-Dubbe syndrome in which tumoral cells may have hybrid features. Angiomyolipoma is usually a benign mesenchymatous neoplasm, that can be sporadic or familial (tuberous sclerosis). In the latter situation, some cases of epithelioid angiomyolipoma (potentially malignant) have been described. Renal epithelial and stromal tumors (REST) is a new concept gathering two benign mixed mesenchymal and epithelial tumors: cystic nephroma and mixed epithelial. and stromal tumors (MEST). (C) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:381 / 401
页数:21
相关论文
共 50 条
  • [21] Modeling of prognostication and differential genomic expression in the tumor microenvironment of clear cell renal cell carcinoma.
    Lee, Sunyoung S.
    Kwon, Seok Joon
    Lee, Dong Eun
    Lee, Seongwon
    Baird, Andrew
    Park, Shinyoung
    Dolan, Jillian
    George, Saby
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [22] Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview
    Bergmann, Lothar
    Weber, Sarah
    Hartmann, Arndt
    Ahrens, Marit
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) : 1273 - 1286
  • [23] The Spectrum of Morphologic Findings in Clear Cell Papillary Renal Cell Carcinoma.
    Williamson, S. R.
    Eble, J. N.
    Cheng, L.
    Grignon, D. J.
    MODERN PATHOLOGY, 2011, 24 : 230A - 231A
  • [24] Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
    Bi, Xiao
    Zhao, Siming
    Adeniran, Adebowale
    Kluger, Harriet M.
    Xie, Zuoquan
    Nawaf, Cayce
    Merino, Maria J.
    Valera, Vladimir
    Pantuck, Allan J.
    Said, Jonathan W.
    Belldegrun, Arie S.
    Lifton, Richard P.
    Shuch, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [25] The Spectrum of Morphologic Findings in Clear Cell Papillary Renal Cell Carcinoma.
    Williamson, S. R.
    Eble, J. N.
    Cheng, L.
    Grignon, D. J.
    LABORATORY INVESTIGATION, 2011, 91 : 230A - 231A
  • [26] Metastasis-associated mutations in clear cell renal cell carcinoma.
    Gowrishankar, Banumathy
    Janakiraman, Manickam
    Lee, Chung-Han
    Thodima, Venkata Jaganmohan
    Molina, Ana M.
    Patel, Premal H.
    Gold, Theresa Margaret
    Motzer, Robert J.
    Chaganti, Raju S. K.
    Kamalakaran, Sitharthan
    Houldsworth, Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [27] Confirmatory integrated proteogenomic characterization of clear cell renal cell carcinoma.
    Clark, David J.
    Li, Yize
    CANCER RESEARCH, 2021, 81 (13)
  • [28] Genomic classification to refine prognosis in clear cell renal cell carcinoma.
    Glennon, Kate I.
    Vasudev, Naveen S.
    Scelo, Ghislaine
    Wilson, Michelle
    Letourneau, Louis
    Eveleigh, Robert
    Nourbehesht, Nazanin
    Arseneault, Madeleine
    Paccard, Antoine
    Egevad, Lars
    Viksna, Juris
    Celms, Edgars
    Jackson, Sharon M.
    Abedi-Ardekani, Behnoush
    Warren, Anne Y.
    Selby, Peter J.
    Trainor, Sebastian
    Kimuli, Michael
    Soomro, Naeem
    Adeyoju, Adebanji
    Patel, Poulam
    Wozniak, Magdalena B.
    Holcatova, Ivana
    Brisuda, Antonin
    Janout, Vladimir
    Chanudet, Estelle
    Zaridze, David
    Moukeria, Anush
    Shangina, Oxana
    Foretova, Lenka
    Navratilova, Marie
    Mates, Dana
    Jinga, Viorel
    Bogdanovic, Ljiljana
    Kovacevic, Bozidar
    Cambon-Thomsen, Anne
    Bourque, Guillaume
    Brazma, Alvis
    Tost, Jorg
    Brennan, Paul
    Lathrop, Mark
    Riazalhosseini, Yasser
    Banks, Rosamonde E.
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Clear cell papillary renal cell carcinoma - An indolent subtype of renal tumor
    Chen, Wei-Jen
    Pan, Chin-Chen
    Shen, Shu-Huei
    Chung, Hsiao-Jen
    Lin, Chih-Chieh
    Lin, Alex T. L.
    Chang, Yen-Hwa
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (10) : 878 - 883
  • [30] Non-clear cell renal cell carcinoma
    Ahrens, Marit
    Bergmann, Lothar
    UROLOGIE, 2024, 63 (12): : 1240 - 1245